New Tool Uses Cancer’s Drug-Resistance Mutations to Target Tumors
SpotNeoMet, a new computational tool, harnesses drug-resistance mutations to create shared neo-antigens for broader immunotherapy against treatment-resistant cancers.
NeoAntigens
Read More